In vitro and cellular assays for palmitoyl acyltransferases using fluorescent lipidated peptides.
Protein palmitoylation is emerging as an important post-translational modification in development as well as in the establishment and progression of diseases such as cancer. This chapter describes the use of fluorescent lipidated peptides to characterize palmitoyl acyltransferase (PAT) activities in vitro and in intact cells. The peptides mimic two motifs that are enzymatically palmitoylated, i.e. C-terminal farnesyl and N-terminal myristoyl sequences. These substrate peptides can be separated from the palmitoylated product peptides by reversed-phase HPLC, detected and quantified by the fluorescence of their NBD label. Through these methods, the activities of PATs toward these alternate substrates in isolated membranes or intact cells can be quantified. The in vitro assay has been used to characterize human PATs and to identify inhibitors of these enzymes. The cellular assay has been useful in elucidating the kinetics of protein palmitoylation by PATs in situ, and the sub-cellular distribution of the palmitoylated products.
Ducker
Charles E
CE
Apogee Biotechnology Corporation, P.O. Box 916, Hershey, PA 17033, USA.
Draper
Jeremiah M
JM
Xia
Zuping
Z
Smith
Charles D
CD
D000217:Acyltransferases / Q000032:analysis*; D005456:Fluorescent Dyes; D008074:Lipoproteins; D019308:Palmitic Acid / Q000378:metabolism*; D010455:Peptides
D005456:Fluorescent Dyes; D008074:Lipoproteins; D010455:Peptides; D019308:Palmitic Acid; D000217:Acyltransferases